SERPINB2 and leukemia: Additionally, SERPINB2 has been identified as a significantly dysregulated gene that regulates the in vivo growth and survival of leukemia stem cells [17], suggesting the possibility that SERPINB2 might act as a regulator or biomarker for predicting metastatic progression in other cancer types, including breast, colorectal and liver cancers.